Relapsing Multiple Sclerosis (RMS)

DBCOND0044896EncephalopathyImmune System Diseases

Relapsing Multiple Sclerosis (RMS) is the indication for 13 drugs in DrugBank. It is covered by 18 curated, structured indications.

Also known as
relapsed Multiple sclerosis · Relapsing Forms of Multiple Sclerosis · relapsing Multiple Sclerosis · Multiple Sclerosis Relapse · Multiple Sclerosis, Relapsing Forms
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10048393UMLSC0856120

What you can answer from here — as of October 22, 2026

13Indicated drugsWith each drug's targets and mechanism
Listed above
18Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
112Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Relapsing Multiple Sclerosis (RMS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In